Germany Confirms Five Zika Virus Cases - hVIVO

MENUMENU

Covid Clear
About Us
- - - About Us
      An industry leading services provider in viral challenge studies and laboratory services supporting product development for customers developing antivirals, vaccines and respiratory therapeutics.
      
      More about hVIVO
Services
- - - Human challenge full-service solution
    - Industry leading provider of viral challenge studies
      
      See Our Solution
  - - hVIVO Challenge Models
  - - Laboratory Services
News, Media & Events
- - - News, Media & Events
      
      A source for the latest press releases, scientific publications and other media as well as details of investor and scientific events that we attend and host across the world.
  - - LATEST PRESS RELEASE
      
      17.02.21 Ethics approval – COVID-19 Human Challenge Study
    - UPCOMING EVENTS
      
      Proactive Investors One2One Investor Forum
      Thursday 11th March
Volunteers
Careers
Contact Us

Germany Confirms Five Zika Virus Cases

January 29, 2016 10:16 am

Follow @hVIVO_UK

Comments are closed here.

Whether you’re a potential customer, job seeker, health professional or an investor, you can find the best way to contact us from the list below.

Contact Us

Terms & Conditions
Careers
Sitemap

© 2021 Copyright hVIVO Services Limited. All rights reserved. hVIVO Services Limited (“hVIVO”) is registered in England and Wales with registration number 02326557 and registered office at Queen Mary BioEnterprises Innovation Centre, 42 New Road, London, E1 2AX, UK.

Privacy Policy | Cookie Policy